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Abstract
Recent studies reported the critical role of the intrauterine environment of a fetus in growth or the development of
disease in adulthood. In this article we discussed the implications of salt restriction in growth of a fetus and the
development of growth-related disease in adulthood. Salt restriction causes retardation of fatal growth or intrauterine
death thereby leading to low birth weight or decreased birth rate. Such retardation of growth along with
the upregulation of the renin angiotensin system due to salt restriction results in the underdevelopment of
cardiovascular organs or decreases the number of the nephron in the kidney and is responsible for onset of
hypertension in adulthood. In addition, gestational salt restriction is associated with salt craving after weaning. Moreover,
salt restriction is associated with a decrease in insulin sensitivity. A series of alterations in metabolism due to salt restriction
are probably mediated by the upregulation of the renin angiotensin system and an epigenetic mechanism including
proinflammatory substances or histone methylation. Part of the metabolic disease in adulthood may be programmed
through such epigenetic changes. The modification of gene in a fetus may be switched on through environment factors
or life style after birth. The benefits of salt restriction have been assumed thus far; however, more precise investigation is
required of its influence on the health of fetuses and the onset of various diseases in adulthood.
Keywords: Salt restriction, Low birth weight, Low birth rate, Programing, Growth retardation, Hypertension, Salt sensitivity,
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Background
Salt is an essential nutrient for all cells and a reduction
in salt intake results in the collapse of cardiovascular cir-
culation. Humans possess more salt-retaining systems,
e.g., hemodynamic, hormonal and renin angiotensin sys-
tems than salt-excreting mechanisms. Therefore, an im-
balance between salt intake and salt-retaining systems is
believed to be responsible for the onset of cardiovascular
disease in adulthood.
With regard to the intrauterine environment, however,
the effects of salt intake by mothers on the fetal growth
have not yet been addressed. In fact, the fetal mechanisms
for coping with a low-salt environment or the impact of
excessive salt restriction on the fetal growth and health
have not been investigated. Given their intrauterine status,
fetuses are more subject than adults to a low-salt environ-
ment and are influenced by salt restriction-related
hemodynamic and hormonal alterations in their mothers
as well as by their own homeostatic changes.
Recent studies have found an association between intra-
uterine growth retardation and cardiovascular dysfunction
with structural changes in both animals and humans. In
this sense, it would be intriguing to determine the patho-
physiological role of maternal salt metabolism in the fetal
growth and to examine whether growth retardation due to
excessive salt restriction is associated with diseases in
adulthood.
Accordingly, this review focuses on recent studies con-
cerning the effects of excessive salt restriction on fetal
growth and reviews the possible mechanism underling
this risk. It is also within our scope to discuss the associ-
ation of growth retardation due to salt restriction with
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hypertension and metabolic diseases in adulthood,
with special reference to epigenetic and gene-related
mechanisms.
Salt restriction and excessive salt intake
In the field of hypertension research, a salt intake of 6 g
per day (equivalent to 2.4 g sodium) has long been
recommended for hypertensive patients, regardless of
the presence of or absence of diabetes or chronic kidney
diseases [1]. However, the average salt intake worldwide
is estimated to be approximately 9.87 (5.45–13.77) g per
day according to public information [2]. The average salt
intake in the United State is approximately 9 g per day,
and less than 5 % US of the population consumes less
than 3.75 g per day [3]. In Japan, the estimated salt in-
take has remained at approximately 10–15 g per day for
decades [4]. Salt intake depends on age, gender and eth-
nicity, and this likely explains the lack of consensus re-
garding defined amounts of sat indicative of restriction
or excessive intake. In general, however, the target
amount for salt restriction is less than 6 g per day, and
6–12 g per day is considered moderate or normal salt in-
take. A salt intake exceeding 12–15 g day might be con-
sidered a high-salt intake in clinical settings. Dietary
Guidelines for Americans 2010 recommends a maximum
dietary sodium intake of 2300 mg per day for the general
population, and the World Health Organization recom-
mends 2000 mg of sodium; however, most Americans con-
sume a higher level of sodium, according to data from the
National Health and Nutrition Examination Survey [4]. In
Canada, a daily salt intake of 3.75 g salt per day is recom-
mended; however, an intake of less than 3 g per day has
been unattainable thus far on a public population. Small
clinical studies, however, have studied severe low-salt
groups, defined as those with a salt intake of less than 1 g
per day. Thus, the definition of salt restriction likely varies
among studies, and in the present review we have
attempted to specify the amount of salt whenever possible.
The findings from animal studies are much clear. The
salt content in regular chow used for rodent colony
maintenance is approximately 0.75 % (w/w). In the field
of hypertension research, a low-salt diet contains 0.3 %
salt (w/w) and a no salt diet contains less than 0.1 % salt
(w/w) [5, 6]. In other words, animals fed a low-salt diet
consume less than half of the usual salt intake. In stud-
ies using Dahl salt sensitive (Dahl S) rats, a high-salt
diet is defined as containing 4 or 8 % salt (w/w), ac-
cording to the definition given by the American Heart
Association hypertension council [5, 6]. A Dahl S rat
weighing 300 g usually consumes approximately 30 g
chow per day, or approximately 0.3 g salt /kg BW per
day for a 0.3 % low-salt diet and 8 g salt/kg BW per
day for an 8 % high-salt diet.
Moreover, there are notably no standard methods with
which to assess salt intake in clinical settings. In small
clinical studies, salt intake is accurately assessed by
determining of the salt content of foods; however, in
large population-based epidemiological studies, it is im-
possible to obtain 24 h urine samples to determine the
urinary excretion of sodium as an index of salt intake.
Thus, salt intake is usually estimated from interviews
concerning ingested foods or via spot urine collection,
which might result in variability in the reported amounts
of salt intake in the literature [7, 8]. Accordingly, in this
review, we have provided information on the methods
used to determine salt intake to the extent possible.
Salt restriction and health risk in offspring
For more than 50 years, the role of salt in health has
been an important topic in the field of public health as
well as in cardiovascular research. Increased salt intake
has been implicated in hypertension and various other
vascular diseases. Whether a lower salt intake is better
for health from a public health standpoint has remained
a matter of debate worldwide [9, 10]. To our surprise,
however, a recent meta-analysis of 25 previous studies
on salt intake and an average 3.7-y observational study
of 101,945 people in 17 countries wherein salt intake
was assessed by determining urinary sodium excretion
demonstrated an association between low-salt intake
and an increase in cardiovascular events/death, com-
pared with normal salt intake [10, 11]. Graudal et al. re-
ported that low sodium intake (less than 115 mol per
day, equivalent to 6.67 g salt) and high sodium intake
(more than 215 mol per day, equivalent to12.47 g salt ),
relative to the usual sodium intake (115–215 mol per
day, equivalent to 6.67–12.47 g salt), were both associ-
ated with increased mortality. There was no difference
between low usual sodium intake (115–165 mol per day,
equivalent to 6.67–9.57 g salt) and high usual sodium in-
take (165–215 mol per day, equivalent to 9.57–12.47 g
salt). This is consistent with a J-shaped association be-
tween sodium intake and health outcomes [10]. Similarly,
a daily sodium intake of 4–5.99 g, equivalent to 10–15 g
salt, estimated on the basis of measured urinary excretion,
was associated with a lower risk of death and cardiovascu-
lar events than either a higher (≥7.0 g sodium per day,
17.5 g salt) or lower salt intake (<3 g sodium per day, 7.5 g
salt) [11]. These studies estimated an optimal salt intake of
approximately 8-10 g salt per day. The mechanism by
which low-salt intake confers this risk is unclear. However,
it is noted that the benefits of blood pressure changes ap-
pear to be small because the blood pressure reduction due
to salt restriction is slight in the range of moderate salt in-
take (7.5–12.5 g salt per day) [12]. On the other hand,
renin angiotensin system is enhanced under conditions of
salt restriction (<3.0 g sodium per day, 7.5 g salt) [11], and
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this presumably promotes cardiovascular and renal injury
mechanisms independently of blood pressure. Despite such
well-designed studies on salt and cardiovascular diseases in
adulthood, few studies have addressed the role of gesta-
tional salt intake in the health of mothers and their
neonates. Intriguingly, however, some studies suggest that
a slight change in intrauterine circumstances influence fetal
growth. In particular, intrauterine growth retardation
(IUGR) due to salt restriction might be possibly related to
the underdevelopment of cardiovascular or metabolic
systems. An interesting hypothesis has been proposed that
some forms of cardiovascular or metabolic diseases in
adulthood are programmed during fetal growth in the
mother’s uterus.
Impaired growth and gestational salt restriction
Salt restriction is associated with low birth and survival
rates and low birth weight. In an animal study, intake of
low-salt (0.3 % NaCl, w/w) chow during mating and ges-
tation is associated with low birth and survival rates of
pups of Dahl salt-sensitive rat pups, compared with pups
from mothers fed a high-salt (4 % NaCl, w/w) diet
(Table 1) [13]. Low-salt intake during mating and preg-
nancy causes an approximately 50 % decrease in birth
rate, with a significantly lowered birth weight. These are
the results of spontaneous abortion or impaired fetal
growth due to salt restriction during pregnancy. The
low-salt chow utilized is approximately 50 % less salt
than the regular chow (0.75 % NaCl, w/w) for maintain-
ing a colony [13, 14]. This suggests that moderate salt
restriction during the perinatal period could be a risk to
the normal intrauterine growth of a fetus.
Moreover, the pup survival rate during lactation was
95 % for mothers on a high-salt diet during pregnancy,
whereas it was as low as 64 % for mothers on the low-
salt (0.3 % NaCl, w/w) diet (Fig. 1) [13]. It is not clear
whether this is related to behavior changes in mothers
due to salt restriction or to babies that possibly have de-
fects critical in intrauterine environments. As shown in
Kaplan Meier analysis there are two types of death, i.e.,
death just after birth and that during normal growth of
pups while taking milk. Since the death is associated
with cannibalism, it is noted that the salt restriction
could cause behavior changes in mothers. More precise
investigation is needed. Moreover, de Siqueira et al. also
reported that Wistar rats with a low-salt intake (0.15 %
NaCl, w/w) in the second half of gestation had low birth
weight and size, thereby suggesting that the salt restric-
tion (0.15 % NaCl, w/w) more likely affects the intrauter-
ine development of the organs of fetuses than normal
sodium diet (1.3 % NaCl, w/w) [15].
In humans, the direct evidence of the etiological associ-
ation of gestational salt restriction and impaired growth of
neonates is limited. Recently, however, there have been a
growing number of studies supporting the hypothesis.
Originally, it was reported that severe morning sickness
and hyperemesis gravida is often associated with low birth
weight or premature labor and the loss of salt resulting
from vomiting is believed to be responsible for both the
low birth rate and low birth weight [16–18]. Moreover,
Shirazki et al. found that babies with low blood sodium
concentrations resulting from their mother’s low-salt
intakes during pregnancy are more likely to be under-
weight at birth [19]. Salt restriction or mineralofluid
loss due to vomiting in pregnancy influences physical
status, and babies born of mothers with extracellular
volume loss by polyethylene glycol more likely crave
salt after birth [19, 20]. Low-salt (0.3 % NaCl, w/w)
solely during gestation is related to the increase of
salt appetite in pups, but after birth the relation
Table 1 Number of mothers that delivered pups
Group Diet (NaCl, w/w) Mother (No) Statisticsa
Mating Pregnant Total Delivered** Babies/Motherb χ2 p vs
MHPR 4.0 % 0.75 % 7 7 7.4 ± 2.3
MLPR 0.3 % 0.75 % 7 4 8.7 ± 1.7 3.82 0.050 MHPR
MRPR 0.75 % 0.75 % 8 7 8.2 ± 1.4 0.94 0.332 MHPR
1.76 0.184 MLPR
1.45 0.228 MRPH
2.33 0.127 MRPL
MRPH 0.75 % 4.0 % 11 11 10.2 ± 1.3
MRPL 0.75 % 0.3 % 11 6 8.8 ± 3.0 6.87 0.011 MRPH
MHPR, mothers fed the high-salt (4 % NaCl, w/w) diet during mating period and the regular (0.75 % NaCl, w/w) chow during pregnant period; MLPR, mothers fed
the low-salt (0.3 % NaCl, w/w) diet during mating period and the regular chow during pregnant period; MRPR, mothers fed the regular chow during mating period
and during pregnant period; MRPH, mothers fed the regular chow during mating period and the high-salt diet pregnant period; MRPL, mothers fed the regular
chow during mating period and the low-salt diet during pregnant period. Total, the total number of mothers; delivered, the number of mothers that gave birth to
pups; non-delivered, the number of mothers that failed to give birth to pups. **The differences in delivered rats were assessed by χ2 test (df = 1). 0.75 % NaCl (w/w)
chow (regular chow) is usually used for maintaining of rat colonies. bmothers that delivered babies.
Cited from Chou R et al. Journal of Nutrition and Metabolism volume 2014. Article ID 212089, (ref# [13]).
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disappears. Low-salt diet (0.3 % NaCl, w/w) in preg-
nancy caused craving for salt in pups compared with
high-salt (4 % NaCl, w/w) mothers whereas after
weaning, salt appetite increases in babies fed a high-
salt (4 % NaCl, w/w) diet compared with those fed a
low-salt (0.3 % NaCl, w/w) diet (Fig. 2) [21–23]. It is
also known that in premature babies, physical and
mental abilities are improved in children whose diets
are supplemented with salt [24].
Mechanism of impaired growth due to salt restriction
The reasons for fewer or low-birth-weight pups being
born of pregnant mothers with salt restrictions remain
unclear. However, low birth weight in response to salt-
restriction during pregnancy is due to alterations of
uterine-placental perfusion [25]. It has also been re-
ported that salt is critical for the development of the
glial (immune) cells in the brain. In fact, it is reported
that salt restriction of 0.022–0.04 % sodium diet caused
retardation of brain development in association with less
consumption of diet, low weight and low survival rate
during lactation in Sprague Dawley rats [26]. Infants
with low sodium intake may experience poor neuro-
logical function in early adolescence, and low-salt intake
impairs the normal development of the nerve sheath in
a fetus. Growth inhibition of astrocytes in the neonate
brain, which occurs because of low-salt intake during
pregnancy, is possibly involved in the dysfunction of
the autonomic system in adulthood, thereby affecting
hemodynamic or metabolic changes in adulthood. Al-
though this hypothesis is interesting, further clinical
trials are required for validation.
Decreased renal blood flow due to low-salt intake usu-
ally enhances the activity of the renin angiotensin sys-
tem, and the enhancement conceivably affects the
intrauterine growth of infants of mothers with salt re-
strictions. In fact, the overexpression of the renin angio-
tensin system in transgenic mice causes a placenta-fetus
imbalance and leads to pre-eclampsia [27–29]. The in-
crease in angiotensin II due to salt restrictions is as-
sumed to cause a placenta-fetus imbalance, and if so, it
may result in low birth rate or low birth weight. More-
over, recent studies have reported an angiotensin II-
mediated epigenetic mechanism for disease expression
or impaired kidney and organ growth during pregnancy
[30–33]. Events that are triggered after a low-salt chal-
lenge, i.e., enhanced regulation of rein angiotensin sys-
tem, are presumed to be involved in gene modification
that become overt through influences after birth. Less
than 3 g sodium/day is expected in general to trigger
renin-angiotensin axis. Moreover, it is well reported that
during critical developmental periods, salt restriction
might affect fetal hormonal, vascular, and renal systems
Fig. 1 Cumulative proportion of offspring survival (Kaplan Meier
analysis). Survival prognosis was evaluated from their birth of the
rat pups to weaning. Open circles refer to the death (complete)
of pups from high-salt (4%NaCl, w/w) intake mothers; solid circles refer to
the (complete) of pups from a low-salt (0.3%NaCl, w/w) intake mothers.
plus (+), censor. The difference was analyzed by Cox's F-Test (T1 = 3.755,
T2 = 2.244, F(2, 8) = 6.6930, p= 0.01958). Cited from Chou R et al. (2014)
Journal of Nutrition and Metabolism volume 2014. Article ID 212089,
(ref# [13]).
Fig. 2 Amounts of saline solutions in the male baby rats from low-and high-salt mothers during gestation and lactation. Cumulative salt intake
for the 4-day in male baby rats from low- (0.3 % NaCl, w/w) and high-salt (4%NaCl) mothers during gestation (left graph) and lactation period
(right graph) **p < 0.005 vs the respective values of low-salt (0.3 % NaCl, w/w) mothers. Cited from Hara A et al. (2014) Food and Nutrition Sciences
Vol.5 No.19, PP. 1904–1913 (ref# [23]).
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to regulate fluid homeostasis in the fetus [34]. Both the
neurohypophysial hormones arginine vasopressin and
oxytocin participating in volume regulation in human
pregnancy and modulating vascular tone are reported to
be impaired in severe sodium (0.46 g/day) restriction
[35]. Such hormonal response might contribute in part
to the impaired growth or death in pups from mothers
on low-salt diet. The details are to be discussed later.
Gestational salt intake and adult hypertension
Since Barker and investigators from other laboratories
reported the association of birth weight and death due
to ischemic heart disease [36], there has been a consider-
able amount of evidence in animal studies suggesting
that low birth weight determines the onset of hyperten-
sion, insulin resistance and lipid dysfunction [37, 38].
The relationship has been consistently confirmed in
humans as well [39–41]. Very large longitudinal study of
13,517 subjects born in Helsinki University Hospital be-
tween 1924 and 1944 clearly demonstrated that small
size at birth and during infancy with accelerated weight
gain from age 3 to 11 years predicts higher incidence of
coronary heart diseases, type 2 diabetes and hyperten-
sion [42]. These diseases are integral components of
metabolic syndrome, and it suggests that intrauterine
process in such a low birth weight fetus programs the
clustering of these disorders in adulthood.
Animal studies have provided some information on
the mechanism that underlies the association. Recently,
Benz and Amann reviewed the role of nephron develop-
ment in the association of maternal nutrition and hyper-
tension [43]. In humans, nephrogenesis occurs from
weeks 5 to 36 of gestation, with the most critical period
being the mid-second trimester until 36 weeks; fetuses
are very sensitive to genetic and environmental factors
such as maternal diet during this 16-week period. This
critical period is in accordance with the data from de
Siqueira et al. suggesting low-salt intake in the second
half of gestation is associated with low birth weight and
size [15]. Such slight changes in intrauterine circum-
stance that cause low birth weight hamper normal
kidney development [44, 45]. A decreased number of
nephrons could conceivably cause salt sensitivity and
thereby developing hypertension in adult offspring. Indeed,
Simonetti et al. found that children with growth-restriction
have a risk for reduced renal mass as determined by ultra-
sound and increased salt sensitivity [46]. A decreased num-
ber of nephrons during gestational development or by
acquired kidney diseases reduce the ability of nephrons to
handle sodium excretion, which leads to the development
of hypertension.
Moreover, salt-restriction during pregnancy enhances
salt-craving in Dahl pups after weaning [13]. Salt-
restriction (0.3 % NaCl, w/w) in gestation causes an
increase in salt-appetite, but the taste of salt does not
change. The association of salt-restriction with an
increase in salt appetite is observed in both male and fe-
male pups. In contrast, high-salt (4 % NaCl, w/w) intake
in mothers during lactation increases the salt appetite in
the pups after weaning. Salt loss in pregnant rats result-
ing from polyethylene glycol intake which produces
extracellular dehydration increases salt-appetite [21]. In
humans it has been well documented that morning sick-
ness and salt-loss due to hormonal dysfunction in neo-
nates in turn enhances salt-appetite later in their babies
[16–20]. Interestingly, Shirazki et al. clearly demon-
strated that in low birth weight children, salt appetite in
children aged 10 years old is negatively related to the
neonatal serum sodium [20]. In general, in animals and
in humans thirst and sodium appetite are programmed
by the developmental environment [47]. Increased salt-
appetite and enhanced salt-sensitivity due to salt-
restriction concurrently increase blood pressure [46]. It
is well known that baby Dahl salt-sensitive pups are
more sensitive to salt-loading than adult rats.
Salt-restriction decreases renal blood flow and triggers
the secretion of renin from the kidney. The increased
plasma renin concentrations initiate the breakdown of
renin substrate, angiotensinogen, and finally, produce
the octapeptide, angiotensin II. The upregulation of
angiotensin II probably influences food preferences. In
very young, normal female subjects, the consumption of
total lipids, cholesterol, and unsaturated free fatty acids
is higher in those with the MM/MT genotype of AGT-
Met235 [48]. In this context, some studies have been
performed to postulate the role of intracerebral angio-
tensin II in water and salt drinking, and it is found that
angiotensin II infusion in the cerebral fluid enhances
behavior of drinking water and salt-appetite [49–51].
Salt-restriction evokes activity of the renin angiotensin
system, and its upregulation due to salt-restriction dur-
ing fetal growth might be associated with an increased
salt-appetite. More directly, sodium depletion produced
marked increases in the dam's plasma angiotensin II and
aldosterone concentrations. During prenatal sodium de-
pletion, the activation of the renin angiotensin system
rather than the loss of sodium itself is responsible for
the modified salt intake behavior [52].
Such changes in renin angiotensin system increases
blood pressure through vasoconstriction, a decrease in
sodium excretion in the kidney, enhanced adrenergic
nervous system and remodeling of the cardiovascular
structure [22]. There is a great deal of evidence suggesting
that intrauterine growth retardation (IUGR) or pre-
eclampsia is associated with an increase in angiotensin II
and that renin angiotensin system plays a critical role in
under-development of intrauterine growth [27, 53–57].
However, the relationship of renin angiotensin system and
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organ growth is somewhat controversial. An intact renin
angiotensin system is necessary for kidney function, and
genetic defects of renin angiotensin system are associated
with kidney abnormalities [58–61]. More directly, suppres-
sion of renin angiotensin system by losartan shortly after
birth is associated with a significantly lower nephron num-
ber with hypertension [62, 63]. Taken together, alterations
of the intrauterine environment might be associated with
either suppression or overexpression of components of the
renin angiotensin system which then potentially contribute
to hypertension by interfering with nephrogenesis.
Salt restriction and insulin resistance
An increasing amount of evidence has suggested that
the programming occurring during gestation may play
an important role in the development of metabolism-
related disorders during adulthood in humans [64–66].
Low birth weight resulting from salt restriction during
pregnancy influences insulin sensitivity and dyslipidemia.
Animal studies have demonstrated that lower glucose
uptake and higher plasma cholesterol and triacylglycerol
concentrations were observed in offspring of salt-
restricted (0.15 % NaCl, w/w) Wistar rat dams than
those in offspring from mothers fed a normal-salt (1.5 %
NaCl, w/w) diet [38]. Vidonho et al. reported that salt
restriction (0.15 % NaCl, w/w) during pregnancy and
lactation in Wistar rat dams decreases glucose uptake
and insulin sensitivity in offspring determined by the
glucose clamp method than high (4 or 8 % NaCl, w/w)
or normal (1.3 % NaCl, w/w) salt diet [37]. This was ac-
companied by higher plasma cholesterol and triacylglyc-
erol concentrations. However, blood pressure was not
necessarily increased in offspring of low-salt (0.15 %
NaCl, w/w) dams, which may be related in part to a dif-
ferent salt appetite in response to salt restriction (0.3 %
NaCl, w/w) during pregnancy and lactation periods as
demonstrated in our previous study [13]. The sensitivity
to salt intake may differ according to growth stage, i.e.,
intrauterine, lactation and after weaning. Unfortunately,
there have been few studies thus far that discuss the
effects of salt in the respective life stage. In this sense,
we will have to wait to determine the exact relationship
between salt intake and effects in adulthood. Despite
such limitations, it has been noted that salt restriction in
pregnant mothers or chronic salt restriction in both ani-
mals and humans is associated with decreased glucose
uptake and insulin sensitivity.
Renin angiotensin system and insulin sensitivity
The association of salt restriction to a decrease in insulin
sensitivity is explained to some extent by the enhance-
ment of renin angiotensin system following chronic salt
restriction. It has been well established in hypertension
research field that enhanced activity of renin angiotensin
system facilitates adrenergic nervous activity in animals
and humans [22, 67]. Upregulation of the α-adrenergic
nervous system increases sodium reabsorption in renal
tubules and induces vasoconstriction, both of which
increase blood pressure [68, 69]. Vasoconstriction by α-
stimulation reduces blood flow in the muscles and β3
adrenoceptor stimulation increases lipolysis and gluco-
neogenesis, thereby mediating type-2 diabetes [70–72].
In this context, Ruivo et al. demonstrated using rats that
α- and β-adrenoceptor blockades or L-arginine, improves
glucose uptake as determined by the glucose clamp
method, thereby increasing insulin sensitivity [73]. Low
birth weight children show an increased heart rate with
enhanced catecholamines and associated with sympathoa-
drenal overactivity after birth [74]. Because there are a
bunch of studies suggesting that renin angiotensin system
underlies the onset of the metabolic syndrome in adult-
hood, it is quite interesting that renin angiotensin system
mediates the association of salt restriction during preg-
nancy with a decrease in insulin sensitivity in adulthood
[75–77]. However, it is not clear whether renin angioten-
sin system is enhanced in intrauterine fetuses in salt-
restricted mothers or if angiotensin II from mothers
affects fetal growth through placental blood flow.
Mechanism of insulin resistance by salt restriction
Renin angiotensin system evokes proinflammatory cyto-
kines, i.e. tumor necrotizing factor (TNF)-α and enhances
oxygen stress through NADPH oxidase activation [78–83].
The proinflammatory cytokines, i.e. TNF-α, interleukin
(IL)-1β, IL-6 and resistin, and nitric oxide (NO) all act on
adipocytes to induce an insulin-resistant state [78]. The al-
terations of subcellular signal transduction in insulin resist-
ance have been extensively investigated. Salt restriction
conceivably induces proinflammatory cytokines-mediated
insulin resistance through upregulated renin angiotensin
system; however, few articles thus far discussed subcellular
signal transduction due to salt restriction. A recent study
has found that high-salt (3.12 % sodium, w/w, equivalent to
7.8 % salt) diet increases insulin sensitivity in Wistar rats
with increased GLUT4 gene expression, and increased in-
sulin signaling, whereas low-salt (0.06 % sodium, w/w,
equivalent to 0.15%salt) diet decreases insulin sensitivity
with impaired insulin signaling [84]. Moreover, Prada et al.
reported that the association of severe salt restriction
(0.15 % NaCl vs high-salt 1.25 % NaCl diet) and insulin re-
sistance and obesity is attributable to c-jun N-terminal
kinase activity [85]. The kinase is involved in the patho-
physiology of obesity and induces insulin resistance by in-
creasing inhibitory IRS-1ser307 phosphorylation. This
demonstrated that salt restriction increases c-jun N-
terminal kinase activity and IRS-1 ser307 phosphorylation,
thereby increasing body weight, visceral adiposity, and
blood glucose and insulin levels with insulin resistance.
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Epigenetics and salt restriction
Epigenetics, the variations in DNA methylation patterns
and chromatin remodeling, provide an intriguing explan-
ation for how environmental factors or intrauterine nu-
trition modify the risk for developing metabolic diseases
in adulthood. However, there are limited data on the in-
fluence of early nutrition on epigenetics modifications
[86]. One example of an epigenetic mechanism is that
uteroplacental insufficiency-induced intrauterine growth
restriction (IUGR), which predisposes to adult-onset in-
sulin resistance, decreases postnatal insulin-like growth
factor-1 (IGF-1) mRNA variants and the gene elongation
mark histone 3 trimethylation of lysine 36 of the IGF-1
gene (H3Me3K36). H3M e3K36 is sensitive to the pre-
natal environment’s glucose level with resultant alteration
of IGF-1 mRNA expression and ultimately vulnerability to
adult-onset insulin resistance [87–89].
The epigenetic mechanism is very promising for explain-
ing the role of salt restriction in developing insulin resist-
ance in adulthood. It has not been proven whether the
enhanced activity of renin angiotensin system due to salt re-
striction mediates indeed the epigenetic mechanism. More-
over, if epigenetic DNA modifications occur, there have
been few studies thus far on phenotype expression resulting
from the epigenetic changes. Renin angiotensin system en-
hances proinflammatory cytokines or oxygen stress and
nFkB-related transcriptional process [81, 83, 90–92]. In this
sense it seems quite interesting to define whether angioten-
sin II participates in epigenetic mechanism with alterations
of oxygen stress. Taken together, the epigenetic hypothesis
promises to explain the late onset of diseases in adulthood.
However, the studies are in their infancy, and the implica-
tions of epigenetic involvement in phenotypic alterations in
adulthood due to salt restriction in pregnant mothers re-
main to be elucidated.
Conclusions
Excess salt intake is believed to be a human health risk,
however, recent studies have drawn attention to the role
of intrauterine environment of fetuses in growth of ba-
bies and development of diseases in adulthood. There
has been an increasing number of studies suggesting that
salt restriction during pregnancy has a critical influence
on the intrauterine growth and development of organs
of fetuses and probably switches on important factors in-
volved in the onset of adult-type diseases through ana-
tomical changes and hemodynamic or hormonal control
including intracellular signal transduction and gene
modification. These links are illustrated in Fig. 3. Salt is
one of the integral components for normal growth of
fetuses. Salt restriction during pregnancy is connected to
IURD or death, low birth weight, organ underdevelop-
ment and dysfunction in adulthood probably through
gene-mediated mechanism. Currently, the hypothesis ap-
pears more complicated, yet, understanding the mecha-
nisms that program fetuses that leads to adult diseases is
expected to provide a new insight for pathogenesis of
cardiovascular and metabolic diseases.
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